One plasma panel consisting of the methylation markers APC, MGMT, RASSF2A, and WIF1 was identified by the present systematic review as promising, by reporting 86% sensitivity and 92% specificity for CRC [45]. The gene discussed is WIF1; the disease is colorectal carcinoma.